Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS
Cofiell, Roxanne, Kukreja, Anjli, Bedard, Krystin, Yan, Yan, Mickle, Angela P., Ogawa, Masayo, Bedrosian, Camille L., Faas, Susan J.
Published in Blood (21.05.2015)
Published in Blood (21.05.2015)
Get full text
Journal Article
Phase I study of samalizumab in chronic lymphocytic leukemia and multiple myeloma: blockade of the immune checkpoint CD200
Mahadevan, Daruka, Lanasa, Mark C, Farber, Charles, Pandey, Manjari, Whelden, Maria, Faas, Susan J, Ulery, Terrie, Kukreja, Anjli, Li, Lan, Bedrosian, Camille L, Zhang, Xiaoping, Heffner, Leonard T
Published in Journal for immunotherapy of cancer (23.08.2019)
Published in Journal for immunotherapy of cancer (23.08.2019)
Get full text
Journal Article
Blockade of CD200 in the Presence or Absence of Antibody Effector Function: Implications for Anti-CD200 Therapy
Kretz-Rommel, Anke, Qin, Fenghua, Dakappagari, Naveen, Cofiell, Roxanne, Faas, Susan J, Bowdish, Katherine S
Published in The Journal of immunology (1950) (15.01.2008)
Published in The Journal of immunology (1950) (15.01.2008)
Get full text
Journal Article
Inhibition of Terminal Complement Components in Presensitized Transplant Recipients Prevents Antibody-Mediated Rejection Leading to Long-Term Graft Survival and Accommodation
Wang, Hao, Arp, Jacqueline, Liu, Weihua, Faas, Susan J, Jiang, Jifu, Gies, David R, Ramcharran, Siobhan, Garcia, Bertha, Zhong, Robert, Rother, Russell P
Published in Journal of Immunology (01.10.2007)
Published in Journal of Immunology (01.10.2007)
Get full text
Journal Article
Correction to: Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab
Cammett, Tobin J, Garlo, Katherine, Millman, Ellen E, Rice, Kara, Toste, Catherine M, Faas, Susan J.
Published in Molecular diagnosis & therapy (01.03.2023)
Published in Molecular diagnosis & therapy (01.03.2023)
Get full text
Journal Article
Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab
Cammett, Tobin J., Garlo, Katherine, Millman, Ellen E., Rice, Kara, Toste, Catherine M., Faas, Susan J.
Published in Molecular diagnosis & therapy (01.01.2023)
Published in Molecular diagnosis & therapy (01.01.2023)
Get full text
Journal Article
Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti–DC-SIGN antibody
Tacken, Paul J., de Vries, I. Jolanda M., Gijzen, Karlijn, Joosten, Ben, Wu, Dayang, Rother, Russell P., Faas, Susan J., Punt, Cornelis J.A., Torensma, Ruurd, Adema, Gosse J., Figdor, Carl G.
Published in Blood (15.08.2005)
Published in Blood (15.08.2005)
Get full text
Journal Article
Inducible Costimulator Regulates Th2-Mediated Inflammation, but Not Th2 Differentiation, in a Model of Allergic Airway Disease
Tesciuba, Amanda G, Subudhi, Sumit, Rother, Russell P, Faas, Susan J, Frantz, Aric M, Elliot, David, Weinstock, Joel, Matis, Louis A, Bluestone, Jeffrey A, Sperling, Anne I
Published in The Journal of immunology (1950) (15.08.2001)
Published in The Journal of immunology (1950) (15.08.2001)
Get full text
Journal Article
In vivo targeting of DC-SIGN-positive antigen-presenting cells in a nonhuman primate model
Pereira, Cândida F, Torensma, Ruurd, Hebeda, Konnie, Kretz-Rommel, Anke, Faas, Susan J, Figdor, Carl G, Adema, Gosse J
Published in Journal of immunotherapy (1997) (01.10.2007)
Published in Journal of immunotherapy (1997) (01.10.2007)
Get more information
Journal Article
Primary Structure and Functional Characterization of a Soluble, Alternatively Spliced Form of B7-1
Faas, Susan J, Giannoni, Michelle A, Mickle, Angela P, Kiesecker, Cheri L, Reed, Deborah J, Wu, Dayang, Fodor, William L, Mueller, John P, Matis, Louis A, Rother, Russell P
Published in The Journal of immunology (1950) (15.06.2000)
Published in The Journal of immunology (1950) (15.06.2000)
Get full text
Journal Article
FP297ECULIZUMAB REDUCES BIOMARKER LEVELS RELATED TO THROMBOTIC MICROANGIOPATHY IN PATIENTS WITH ATYPICAL HAEMOLYTIC URAEMIC SYNDROME: CORRELATION TO RENAL FUNCTION IMPROVEMENT
Cofiell, Roxanne, Kukreja, Anjli, Bedard, Krystin, Yan, Yan, Mickle, Angela P, Ogawa, Masayo, Bedrosian, Camille L, Faas, Susan J
Published in Nephrology, dialysis, transplantation (01.05.2015)
Published in Nephrology, dialysis, transplantation (01.05.2015)
Get full text
Journal Article
First-In-Human Phase I Dose Escalation Study of a Humanized Anti-CD200 Antibody (Samalizumab) In Patients with Advanced Stage B Cell Chronic Lymphocytic Leukemia (B-CLL) or Multiple Myeloma (MM)
Mahadevan, Daruka, Lanasa, Mark C, Whelden, Maria, Faas, Susan J, Ulery, Terrie L, Kukreja, Anjli, Li, Lan, Bedrosian, Camille L, Heffner, Leonard T
Published in Blood (19.11.2010)
Published in Blood (19.11.2010)
Get full text
Journal Article